Top Clinical Trials companies in Australia by Net Cash Used Provided By Financing Activities

This ranking features the top 15 Clinical Trials companies in Australia ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD -909.11 M, for February 07, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 243.73 M
June 30, 2024 NA

Australia

2
USD 76.82 M
June 30, 2024 USD 2.34 -4.83%

Australia

3
USD 63.46 M
June 30, 2024 USD 2.09 0.97%

Australia

4
USD 49.68 M
Dec. 31, 2023 USD 6.22 1.04%

Australia

5
USD 40.25 M
June 30, 2024 USD 1.84 -3.30%

Australia

6
USD 6.94 M
Dec. 31, 2023 USD 18.31 -0.05%

Australia

7
USD 6.15 M
June 30, 2024 USD 4.80 5.03%

Australia

8
USD 552.74
June 30, 2024 USD 2.04 -5.56%

Australia

9
USD 0.00
June 30, 2024 USD 1.67 2.45%

Australia

10
USD -2.11 M
June 30, 2024 USD 1.23 0.02%

Australia

11
USD -2.38 M
June 30, 2024 USD 7.25 -0.16%

Australia

12
USD -3.28 M
June 30, 2024 USD 0.74 0.02%

Australia

13
USD -6.93 M
June 30, 2024 USD 0.74 0.02%

Australia

14
USD -97.44 M
June 30, 2024 USD 2.33 0.29%

Australia

15
USD -1.28 B
June 30, 2024 USD 171.50 0.95%

Australia

Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Australia with the highest Net Cash Used Provided By Financing Activities is Opthea Limited (ASX: OPT.AX) at USD 243.73 M.

  • Which Clinical Trials company in Australia has the lowest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Australia with the lowest Net Cash Used Provided By Financing Activities is CSL Limited (ASX: CSL.AX) at USD -1.28 B.

SV Wall Street